(Q36006519)

11 August 2017

1 reference

title

Cytochrome p450 enzymes and cardiovascular disease (English)

1 reference

11 August 2017

Arwen L Hunter

1

1 reference

11 August 2017

Rani P Cruz

2

1 reference

11 August 2017

Bo M Cheyne

3

1 reference

11 August 2017

Bruce M McManus

4

1 reference

11 August 2017

David J Granville

5

1 reference

11 August 2017

publication date

1 December 2004

1 reference

Canadian Journal of Physiology and Pharmacology

11 August 2017

published in

1 reference

11 August 2017

volume

82

1 reference

11 August 2017

issue

12

1 reference

11 August 2017

page(s)

1053-1060

1 reference

Short-term acetaldehyde exposure depresses ventricular myocyte contraction: role of cytochrome P450 oxidase, xanthine oxidase, and lipid peroxidation

11 August 2017

cites work

1 reference

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

21 January 2018

1 reference

Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation

21 January 2018

1 reference

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts

21 January 2018

1 reference

Cytochrome P450 2C is an EDHF synthase in coronary arteries

21 January 2018

1 reference

Cytochrome p450 and vascular homeostasis

21 January 2018

1 reference

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

21 January 2018

1 reference

Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure

21 January 2018

1 reference

Genome sequence of the Brown Norway rat yields insights into mammalian evolution

21 January 2018

1 reference

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors

21 January 2018

1 reference

Cytochrome P450 enzymes in the generation of commercial products

21 January 2018

1 reference

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

21 January 2018

1 reference

Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension

21 January 2018

1 reference

Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin

21 January 2018

1 reference

Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels

21 January 2018

1 reference

20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells.

21 January 2018

1 reference

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.

21 January 2018

1 reference

20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure

21 January 2018

1 reference

Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells

21 January 2018

1 reference

20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive rats.

21 January 2018

1 reference

Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1.

21 January 2018

1 reference

Mechanisms of cytochrome P450 regulation by inflammatory mediators.

21 January 2018

1 reference

Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy

21 January 2018

1 reference

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

21 January 2018

1 reference

P-450 metabolites of arachidonic acid in the control of cardiovascular function

21 January 2018

1 reference

Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart

21 January 2018

1 reference

Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension

21 January 2018

1 reference

Association between aldosterone synthase (CYP11B2) gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy

21 January 2018

1 reference

Testosterone, cytochrome P450, and cardiac hypertrophy

21 January 2018

1 reference

Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?

21 January 2018

1 reference

Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C9*1/*3 genotype

21 January 2018

1 reference

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

21 January 2018

1 reference

Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart

21 January 2018

1 reference

Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs

21 January 2018

1 reference

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction

21 January 2018

1 reference

Cardiac steroidogenesis in the normal and failing heart.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y04-118

1 reference

11 August 2017

1 reference